Literature DB >> 16637015

Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry.

Da-Qiang Li1, Lei Wang, Fei Fei, Yi-Feng Hou, Jian-Min Luo, Rong Zeng, Jiong Wu, Jin-Song Lu, Gen-Hong Di, Zhou-Luo Ou, Qi-Chang Xia, Zhen-Zhou Shen, Zhi-Min Shao.   

Abstract

To better understand the molecular mechanisms underlying breast cancer metastasis and search for potential markers for metastatic progression, we have developed a highly metastatic variant of human MDA-MB-435 breast cancer cell line through in vivo stepwise selection of pulmonary metastatic cells caused by parental MDA-MB-435 cells in the athymic mice. Comparative proteomic analysis using 2-DE and LC-IT-MS revealed that 102 protein spots were reproducibly altered more than three-fold between the selected variant and its parental counterpart. Eleven differentially expressed protein spots were identified with high confidence using SEQUEST with uninterpreted tandem mass raw data. Cathepsin D precursor, peroxiredoxin 6 (PDX6), heat shock protein 27 (HSP27), HSP60, tropomyosin 1 (TPM1), TPM2, TPM3, TPM4, 14-3-3 protein epsilon, and tumor protein D54 were up-regulated in the highly metastatic variant, whereas alpha B-crystalline (CRAB) was only detected in its parental counterpart. Differential expression was confirmed for four proteins including PDX6, CRAB, TPM4, and HSP60 by real-time quantitative PCR and Western blotting analysis in our model. Immunohistochemical analysis in 80 breast cancer donors demonstrated a significant association of TPM4 (p = 0.002), HSP60 (p = 0.001), PDX6 (p = 0.002) but not CRAB (p = 0.113) staining with the presence of lymph node metastasis. In addition, TPM4 staining was also associated with clinical stage (p = 0.000), but no significant association was found between TPM4, PDX6, CRAB, and HSP60 expression and tumor size, hormone receptor, and HER-2 status (p > 0.05). The functional implication of these identified proteins was also discussed. These proteomic data are valuable and informative for understanding breast cancer metastasis and searching for potential markers for metastatic progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16637015     DOI: 10.1002/pmic.200500617

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  56 in total

1.  Toll-like receptor 3 acts as a suppressor gene in breast cancer initiation and progression: a two-stage association study and functional investigation.

Authors:  Lei Fan; Peng Zhou; Qi Hong; Ao-Xiang Chen; Guang-Yu Liu; Ke-Da Yu; Zhi-Ming Shao
Journal:  Oncoimmunology       Date:  2019-03-30       Impact factor: 8.110

2.  Investigation of molecular factors associated with malignant transformation of oligodendroglioma by proteomic study of a single case of rapid tumor progression.

Authors:  Chul-Kee Park; Jin Hyun Kim; Min Jeong Moon; Ji Hye Jung; Su-Young Lim; Sung-Hye Park; Jong-Hoon Kim; Dong Gyu Kim; Hee-Won Jung; Byung-Kyu Cho; Sun Ha Paek
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-26       Impact factor: 4.553

3.  Epigenomic alterations in localized and advanced prostate cancer.

Authors:  Pei-Chun Lin; Eugenia G Giannopoulou; Kyung Park; Juan Miguel Mosquera; Andrea Sboner; Ashutosh K Tewari; Levi A Garraway; Himisha Beltran; Mark A Rubin; Olivier Elemento
Journal:  Neoplasia       Date:  2013-04       Impact factor: 5.715

4.  Clinical and biological significance of EZH2 expression in endometrial cancer.

Authors:  Ju-Won Roh; Jung Eun Choi; Hee Dong Han; Wei Hu; Koji Matsuo; Masato Nishimura; Ju-Seog Lee; Sun Young Kwon; Chi Heum Cho; Jongseung Kim; Robert L Coleman; Gabriel Lopez-Bernstein; Anil K Sood
Journal:  Cancer Biol Ther       Date:  2019-10-22       Impact factor: 4.742

5.  Allelic variants of glutathione S-transferase P1-1 differentially mediate the peroxidase function of peroxiredoxin VI and alter membrane lipid peroxidation.

Authors:  Y Manevich; S Hutchens; K D Tew; D M Townsend
Journal:  Free Radic Biol Med       Date:  2012-11-06       Impact factor: 7.376

6.  Expression of the molecular chaperone αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof: an immunohistochemical and proteomics-based strategy.

Authors:  Maria Kabbage; Mounir Trimeche; Hela Ben Nasr; Philippe Hammann; Lauriane Kuhn; Bechr Hamrita; Anouar Chaieb; Lotfi Chouchane; Karim Chahed
Journal:  Tumour Biol       Date:  2012-09-13

7.  PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases.

Authors:  Lisa M Kaminskas; David B Ascher; Victoria M McLeod; Marco J Herold; Caroline P Le; Erica K Sloan; Christopher J H Porter
Journal:  J Control Release       Date:  2013-03-15       Impact factor: 9.776

8.  Comparative proteomics and molecular mechanical analysis in CDA-II induced therapy of LCI-D20 hepatocellular carcinoma model.

Authors:  Hui-zhi Fan; Hang Liu; Chen Zhang; Dong-mei Gao; Qun Xue; Jun Chen; Rui-xia Sun; Yin-kun Liu; Peng-yuan Yang
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-14       Impact factor: 4.553

9.  Calreticulin expression in infiltrating ductal breast carcinomas: relationships with disease progression and humoral immune responses.

Authors:  Maria Kabbage; Mounir Trimeche; Sarra Bergaoui; Philippe Hammann; Lauriane Kuhn; Bechr Hamrita; Hela ben Nasr; Anouar Chaieb; Lotfi Chouchane; Karim Chahed
Journal:  Tumour Biol       Date:  2013-01-22

10.  A Comparison of the Proteomic Expression in Pooled Saliva Specimens from Individuals Diagnosed with Ductal Carcinoma of the Breast with and without Lymph Node Involvement.

Authors:  Charles F Streckfus; Karen A Storthz; Lenora Bigler; William P Dubinsky
Journal:  J Oncol       Date:  2009-12-20       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.